In B-cell Lymphoma, HLA class 1 molecules, which typically activate CD8+ cytotoxic T cells (CTL) to directly kill tumors, are missing a key β-2 microglobulin subunit which results in immune escape for the tumor [18]. Here, CD8A is linked to neoplasm.